| Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
|---|
| 02/19/2004 | US20040034088 For treating microbial/fungal infections |
| 02/19/2004 | US20040034055 For treating central nervous system disorders, immunomodulatory disorders, antimalaria, viral disease of Borna virus, Hepatitis; a 6-azatricyclo(6.3.1.01,6)dodecane derivatives |
| 02/19/2004 | US20040034052 Antitumor agents |
| 02/19/2004 | US20040034019 Piperazine and piperidine derivatives |
| 02/19/2004 | US20040033995 Nitrogen compounds, stereoisomers and/or racemic mixtures used as enzyme inhibitors for prophylaxis of inflammatory diseases |
| 02/19/2004 | US20040033962 Antibody directed enzyme prodrug therapy |
| 02/19/2004 | US20040033910 Bicyclic thioamides as additives for lubricating oils |
| 02/19/2004 | DE10235945A1 New 4-(3-substituted benzoyl)-pyrazol-5-one derivatives, useful as broad-spectrum, pre- and post-emergence herbicides especially for selective weed control in crops e.g. wheat, maize and rice |
| 02/19/2004 | DE10233500A1 3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylen]-6-methoxycarbonyl-2-indolinon-Monoethansulfonat und dessen Verwendung als Arzneimittel and its use as a medicament |
| 02/19/2004 | CA2495108A1 Therapeutic use of aryl amino acid derivatives |
| 02/19/2004 | CA2494086A1 Metallic complexes covalently bound to conjugated polymers and electronic devices containing such compositions |
| 02/19/2004 | CA2493575A1 Tyrosine kinase inhibitors |
| 02/19/2004 | CA2493143A1 2,3-dihydro-isoindol-1-ones with mao-b inhibiting activity |
| 02/18/2004 | EP1389203A2 Analogs of thalidomide as potential angiogenesis inhibitors |
| 02/18/2004 | EP1389189A2 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 02/18/2004 | EP1389185A2 Aminoalcohol derivatives |
| 02/18/2004 | EP1389104A2 3-aminoalkyl-2-aryl-indole derivatives and their use as gnrh antagonists |
| 02/18/2004 | EP1389103A2 Synthesis and evaluation of novel phthalimide mimics as anti-angiogenic agents |
| 02/18/2004 | EP1178958B1 N-cyanomethyl amides as protease inhibitors |
| 02/18/2004 | EP1171416B1 3-bicycloaryl-2-aminomethyl bicycloalkanes as serotonine reuptake inhibitors |
| 02/18/2004 | EP0946166B1 Use of matrix metalloproteinase inhibitors for promoting wound healing |
| 02/18/2004 | EP0918781B1 Asymmetric synthesis catalyzed by transition metal complexes with cyclic chiral phosphine ligands |
| 02/18/2004 | EP0851857B1 Inhibitors of tumor necrosis factor alpha |
| 02/18/2004 | CN1476432A Indole and dihydroindole derivatives |
| 02/18/2004 | CN1138789C Method of producing network structure of polymer |
| 02/18/2004 | CN1138755C Cyclic amino acids and derivs thereof useful as pharmaceutical agents |
| 02/17/2004 | US6693199 Deprotecting carbamate group and amidating in presence of such as hydroxybenzotriazole hydrate promoter |
| 02/17/2004 | US6693123 (4-(3-pyridylaminomethylene)-2-phenylbenzoyl)-n -methylmethionine, methyl ester for example; restenosis, hyperplasia |
| 02/17/2004 | US6693111 Indole-2,3-dione-3-oxime derivatives |
| 02/17/2004 | US6693105 Using xanthinyl derivatives to reduce treatment induced toxicity; inhibiting cellular signaling through second messenger pathway; reducing cellular level of nonarachi-donate phosphatidic acid and diacylglycerol |
| 02/17/2004 | US6693098 Carboxylic acid or tetrazole derivatives containing carbamate groups are useful for treating the conditions associated with the urinary tract, pain, inflammation, respiratory states, edema formation of hypotensive vascular diseases |
| 02/17/2004 | US6693092 Herbicides; pesticides |
| 02/12/2004 | WO2004013282A2 Bis (amino acid) molecular scaffolds |
| 02/12/2004 | WO2004013127A1 Method for producing highly pure hydroxy indolyl glyoxylic acid amides |
| 02/12/2004 | WO2004013117A1 Bicyclic cylopentanone and cyclopentenone derivatives as potent activators of hsf |
| 02/12/2004 | WO2004013099A1 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition |
| 02/12/2004 | WO2004013094A2 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 02/12/2004 | WO2004013087A1 Anthranyl derivatives having an anticholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof |
| 02/12/2004 | WO2004013085A1 3-amino-2-hrydroxyalkanoic acids and their prodrugs |
| 02/12/2004 | WO2004013072A2 Copper catalyzed arylation |
| 02/12/2004 | WO2004012722A2 Bicifadine formulation |
| 02/12/2004 | WO2004012648A2 Substituted diaryl heterocycles, method for the production and use thereof as medicaments |
| 02/12/2004 | WO2003049702A3 Vanilloid receptor ligands and their use in treatments |
| 02/12/2004 | WO2002030406A3 Use of antagonists or partial agonists of 5ht1a receptors for the preparation of a medicament for treatment and prevention of gastrointestinal diseases |
| 02/12/2004 | US20040030154 Isolation of tryptophan; controlling nervous system response; contactor with porous carriers; agitation aqueous solution |
| 02/12/2004 | US20040030072 Using coordination catalyst |
| 02/12/2004 | US20040029950 Nervous system and psychological disorders |
| 02/12/2004 | US20040029948 Antiinflammatory agents; sepsis shock; rheumatic disorders |
| 02/12/2004 | US20040029913 Halogenated selective androgen receptor modulators and methods of use thereof |
| 02/12/2004 | US20040029889 Bone disorders; antiarrhythmia agents; cardiovascular disorders |
| 02/12/2004 | US20040029871 Pharmaceutical compounds for treating copd |
| 02/12/2004 | US20040029814 Cathepins inhibitor; antiinflammatory agents; antiarthritic agents |
| 02/12/2004 | US20040029813 Cardiovascular disorders; hypotensive agents; angiotensin converting enzyme inhibitor |
| 02/12/2004 | DE10233817A1 Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted Diarylheterocyclen, processes for their preparation and their use as medicaments |
| 02/12/2004 | DE10233366A1 In 6-Stellung substituierte Indolinonderivate, ihre Herstellung und ihre Verwendung als Arzneimittel In the 6-position substituted indolinone derivatives, their preparation and their use as medicaments |
| 02/12/2004 | CA2494632A1 3-amino-2-hrydroxyalkanoic acids and their prodrugs |
| 02/12/2004 | CA2494404A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 02/12/2004 | CA2494142A1 Copper catalyzed arylation |
| 02/12/2004 | CA2493982A1 Method for producing highly pure hydroxy indolyl glyoxylic acid amides |
| 02/12/2004 | CA2493593A1 Bicifadine formulation |
| 02/11/2004 | EP1388535A1 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 02/11/2004 | EP1387827A2 Synthesis of cyclopentadiene derivatives |
| 02/11/2004 | EP1387826A1 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors |
| 02/11/2004 | EP1240157B1 Substituted n-benzyl-indol-3-yl glyoxylic acid derivatives having an anti-tumoral effect |
| 02/11/2004 | EP1216239B1 Piperazine derivatives as 5-ht1b antagonists |
| 02/11/2004 | EP1176987B1 Short-chain peptide dye conjugates used as contrast agents for optical diagnostics |
| 02/11/2004 | EP1047411B1 Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation |
| 02/11/2004 | EP1028725B1 Use of vasopressin antagonists for treating disturbances or illnesses of the inner ear |
| 02/11/2004 | EP0812825B1 Propenone derivatives |
| 02/11/2004 | CN1474804A 2-amino-2-alkyl-4-hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/11/2004 | CN1474691A Novel uses of combined 5-HT 1A agonists and serotonin reuptake inhibitor |
| 02/11/2004 | CN1473814A Intemediate for preparing alkyl-dihalogeno phenyl substituted keto-enol |
| 02/11/2004 | CN1137894C Pyridopyranoazepine derivatives, preparation and therapeutic use |
| 02/11/2004 | CN1137884C Indazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use |
| 02/10/2004 | US6689881 Method for preparing substituted [1,4]diazepino[6,7,1-hi]indol-4-ones |
| 02/10/2004 | US6689806 Indolinone compounds as kinase inhibitors |
| 02/10/2004 | US6689792 Useful for the treatment of schizophrenia and related psychotic disorders such as parkinson's disease and alzheimer's disease |
| 02/10/2004 | US6689784 Controlling cell apoptosis |
| 02/10/2004 | US6689523 Charge transport compound containing bis(3-formylcarbazolyl)-1,1'-(sulfonyldi-4, 1-phenylene)bis-hydrazones |
| 02/05/2004 | WO2004011556A1 Site-specific labelling of proteins using cyanine dye reporters |
| 02/05/2004 | WO2004011438A1 Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect |
| 02/05/2004 | WO2004011425A2 Indole, azaindole and related heterocyclic ureido and thioureido piperazine derivatives |
| 02/05/2004 | WO2004011410A1 Chemical compounds |
| 02/05/2004 | WO2004010761A2 Pesticidal cyanine dye derivatives |
| 02/05/2004 | WO2003075857A3 Amino-methyl substituted tetracycline compounds |
| 02/05/2004 | WO2003070703A3 Hydroxylated indirubin derivatives |
| 02/05/2004 | WO2003064388A3 Process for the preparation of high purity perindopril and intermediates useful in the synthesis |
| 02/05/2004 | US20040024211 Such as (3S)-N-(2-(2-(2,4-dichlorophenyl)ethyl)-1-oxo-2,3-dihydro-1H-isoindol-5-yl) -3-methyl-N'-((1S,2S,3S,5R)-2,6,6-trimethylbicyclo(3.1.1)hept-3 -yl)piperazine-1-carboximidamide for treatment of obesity or type II diabetes |
| 02/05/2004 | US20040024190 Viral polymerase inhibitors |
| 02/05/2004 | US20040024132 A free radical polymerization in presence of a sulfur based chain transfer agents, controlling during the synthesis of polystyrene, polymethyl acrylate, polymethyl methacrylate |
| 02/05/2004 | US20040024067 Deacetylase inhibitors |
| 02/05/2004 | US20040024057 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use related applications |
| 02/05/2004 | US20040024045 Glucagon antagonists/inverse agonists |
| 02/05/2004 | US20040024023 1-Heterocyclylalkyl-3-sulfonyl-indole or -indazole derivatives as 5-hydroxytryptamine-6 ligands |
| 02/05/2004 | US20040024010 3-methylidenyl-2-indolinone modulators of protein kinase |
| 02/05/2004 | US20040023999 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/05/2004 | US20040023890 Drugs for diabetes |
| 02/05/2004 | US20040023060 Structure including at least three planar moieties, which are linearly configured such that one planar moiety is located between two neighboring planar moieties and shares an atom with each of the moieties |
| 02/05/2004 | US20040022856 Carriers for drug delivery |
| 02/05/2004 | US20040020791 Electrochemical assays |